Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Glioma 20 Glioblastoma 15 Brain Neoplasms 11 Neuroblastoma 4 Neoplasms 4 Astrocytoma 4 Sarcoma 3 Prostatic Neoplasms 2 Neurofibromatosis 1 2 Neoplastic Cells, Circulating 2 Meningioma 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Radiation Injuries 1 Polycystic Kidney, Autosomal Recessive 1 Pituitary Neoplasms 1 Pheochromocytoma 1 Parkinsonian Disorders 1 Paraganglioma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Oligodendroglioma 1 Neurofibromatosis-Noonan syndrome 1 Neurofibromatoses 1 Neoplasms, Germ Cell and Embryonal 1

Interventions

3-Iodobenzylguanidine 8 lutetium Lu 177 dotatate 6 gallium Ga 68 dotatate 5 Temozolomide 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 anlotinib 3 Everolimus 3 olaparib 2 cabozantinib 2 belzutifan 2 Sunitinib 2 Phenoxybenzamine 2 Nivolumab 2 Fluorodeoxyglucose F18 2 Biopsy 2 Axitinib 2 3-fluorobenzylguanidine 2 177Lu-octreotide, DOTA(0)-Tyr(3)- 2 vandetanib 1 talazoparib 1 spartalizumab 1 pembrolizumab 1 pazopanib 1 lanreotide 1 guadecitabine 1 fluorodopa F 18 1 fludarabine phosphate 1 copper dotatate CU-64 1 cixutumumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Paraganglioma × Blood Specimen Collection × CNS × Clear all

NCT06444607 2024-11-21

HEPHESTOS

Radboud University Medical Center

Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡